Scott B. Capps, VP, Clinical Research at CRYOLIFE INC (CRY), sold 22,166 shares at $16.40 ($364K) on 2017-02-22, disclosed to the SEC on 2017-02-24.
Seasonal sale ($364k) by VP, Clinical Research — this insider has traded CRY in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.40 | 11,083 | $182K | 50.0% |
| 2 | $16.40 | 11,083 | $182K | 50.0% |
| Total | $16.40 avg | 22,166 | $364K | 100% |
| Filing → |
| CRY | SELL | 2019-06-03 | $57K | — | Filing → |
| CRY | SELL | 2018-09-04 | $432K | — | Filing → |
| CRY | SELL | 2016-02-23 | $155K | — | Filing → |